These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Detection of Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Bradshaw CS; Birnie J; Ebeyan S; Lundgren M; Murray G J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33612146 [No Abstract] [Full Text] [Related]
5. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018. Ke W; Li D; Tso LS; Wei R; Lan Y; Chen Z; Zhang X; Wang L; Liang C; Liao Y; Chen H; Liu Y; Zheng H; Yang L BMC Infect Dis; 2020 Dec; 20(1):950. PubMed ID: 33308173 [TBL] [Abstract][Full Text] [Related]
6. Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis. Chambers LC; Jensen JS; Morgan JL; Lowens MS; Romano SS; Totten PA; Soge OO; Hughes JP; Golden MR; Manhart LE Sex Transm Dis; 2019 Dec; 46(12):805-809. PubMed ID: 31259853 [TBL] [Abstract][Full Text] [Related]
7. Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance. Couldwell DL; Tagg KA; Jeoffreys NJ; Gilbert GL Int J STD AIDS; 2013 Oct; 24(10):822-8. PubMed ID: 24052013 [TBL] [Abstract][Full Text] [Related]
8. Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure. Vodstrcil LA; Plummer EL; Doyle M; Murray GL; Bodiyabadu K; Jensen JS; Whiley D; Sweeney E; Williamson DA; Chow EPF; Fairley CK; Bradshaw CS Clin Infect Dis; 2022 Sep; 75(5):813-823. PubMed ID: 34984438 [TBL] [Abstract][Full Text] [Related]
9. Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains. Hamasuna R; Le PT; Kutsuna S; Furubayashi K; Matsumoto M; Ohmagari N; Fujimoto N; Matsumoto T; Jensen JS PLoS One; 2018; 13(6):e0198355. PubMed ID: 29883482 [TBL] [Abstract][Full Text] [Related]
10. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan. Deguchi T; Ito S; Yasuda M; Kondo H; Yamada Y; Nakane K; Mizutani K; Tsuchiya T; Yokoi S; Nakano M J Infect Chemother; 2017 Sep; 23(9):648-650. PubMed ID: 28462860 [TBL] [Abstract][Full Text] [Related]
11. Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan. Kikuchi M; Ito S; Yasuda M; Tsuchiya T; Hatazaki K; Takanashi M; Ezaki T; Deguchi T J Antimicrob Chemother; 2014 Sep; 69(9):2376-82. PubMed ID: 24894419 [TBL] [Abstract][Full Text] [Related]
12. Macrolide and fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Johannesburg, South Africa, 2007-2014. Muller EE; Mahlangu MP; Lewis DA; Kularatne RS BMC Infect Dis; 2019 Feb; 19(1):148. PubMed ID: 30760230 [TBL] [Abstract][Full Text] [Related]
13. Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV. Deguchi T; Kikuchi M; Yasuda M; Ito S J Infect Chemother; 2015 Jan; 21(1):74-5. PubMed ID: 25245990 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS Lancet Infect Dis; 2020 Nov; 20(11):1302-1314. PubMed ID: 32622378 [TBL] [Abstract][Full Text] [Related]
16. Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. Shimada Y; Deguchi T; Nakane K; Masue T; Yasuda M; Yokoi S; Ito S; Nakano M; Ito S; Ishiko H Int J Antimicrob Agents; 2010 Sep; 36(3):255-8. PubMed ID: 20580532 [TBL] [Abstract][Full Text] [Related]
17. gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy. Murray GL; Plummer EL; Bodiyabadu K; Vodstrcil LA; Huaman JL; Danielewski JA; Chua TP; Machalek DA; Garland S; Doyle M; Sweeney EL; Whiley DM; Bradshaw CS Clin Infect Dis; 2023 Jun; 76(12):2187-2195. PubMed ID: 36722416 [TBL] [Abstract][Full Text] [Related]
18. Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium. Fernández-Huerta M; Bodiyabadu K; Esperalba J; Bradshaw CS; Serra-Pladevall J; Garland SM; Fernández-Naval C; Jensen JS; Pumarola T; Ebeyan S; Lundgren M; Tan LY; Espasa M; Murray GL J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434719 [No Abstract] [Full Text] [Related]
19. Surveillance of the prevalence of macrolide and/or fluoroquinolone resistance-associated mutations in Mycoplasma genitalium in Japan. Deguchi T; Ito S; Yasuda M; Sato Y; Uchida C; Sawamura M; Manda K; Takanashi M; Kiyota H J Infect Chemother; 2018 Nov; 24(11):861-867. PubMed ID: 30190106 [TBL] [Abstract][Full Text] [Related]
20. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Bissessor M; Tabrizi SN; Twin J; Abdo H; Fairley CK; Chen MY; Vodstrcil LA; Jensen JS; Hocking JS; Garland SM; Bradshaw CS Clin Infect Dis; 2015 Apr; 60(8):1228-36. PubMed ID: 25537875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]